Eramet S.a.
ERMAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,933 | $3,340 | $5,014 | $3,710 |
| % Growth | -12.2% | -33.4% | 35.1% | – |
| Cost of Goods Sold | $1,219 | $1,341 | $3,780 | $2,906 |
| Gross Profit | $1,714 | $1,999 | $1,234 | $762 |
| % Margin | 58.4% | 59.9% | 24.6% | 20.5% |
| R&D Expenses | $0 | $0 | $17 | $21 |
| G&A Expenses | $0 | $0 | $0 | $1,149 |
| SG&A Expenses | $0 | $240 | -$12 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,663 | $1,952 | $37 | $18 |
| Operating Expenses | $1,663 | $2,192 | $42 | $41 |
| Operating Income | $51 | -$193 | $1,025 | $879 |
| % Margin | 1.7% | -5.8% | 20.4% | 23.7% |
| Other Income/Exp. Net | -$9 | $293 | $169 | $9 |
| Pre-Tax Income | $42 | $100 | $1,194 | $888 |
| Tax Expense | $94 | $88 | $264 | $98 |
| Net Income | $14 | $109 | $740 | $298 |
| % Margin | 0.5% | 3.3% | 14.8% | 8% |
| EPS | 0.49 | 3.54 | 25.81 | 10.43 |
| % Growth | -86.2% | -86.3% | 147.5% | – |
| EPS Diluted | 0.49 | 3.77 | 25.48 | 10.39 |
| Weighted Avg Shares Out | 28 | 31 | 29 | 29 |
| Weighted Avg Shares Out Dil | 28 | 29 | 29 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50 | $39 | $10 | $9 |
| Interest Expense | $202 | $159 | $116 | $114 |
| Depreciation & Amortization | $238 | $229 | $271 | $259 |
| EBITDA | $469 | $244 | $1,324 | $1,150 |
| % Margin | 16% | 7.3% | 26.4% | 31% |